A five-year retrospective study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center and published in ...
A real-world comparison of two androgen receptor pathway inhibitors (ARPIs) for advanced prostate cancer showed a significant difference in overall survival (OS).
For generations, medical students were taught that the map of the human body was essentially complete. Yet cancer imaging has ...
On World Cancer Day, we shine a light on the silent killers: rare and deadly cancers that often go unnoticed.
A cancer treatment center funded by a grant from the Ralph Lauren Corporate Foundation will open this year at UChicago ...
Cancer treatment is entering a new era, driven by advances in precision medicine, AI, and targeted therapies known as theranostics. In this episode of Today in Tech, Keith Shaw speaks with Douglas ...
Fusion prostate biopsy of prostate imaging report and data system lesions has become an integral part of diagnosis of prostate cancer. Though the scoring system is slightly different between ...
A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate. The study opens the door to potential new treatments for bacterial ...
Abstract: The transperineal approach in prostate interventions is increasingly favored for its lower infection risk and enhanced targeting accuracy. However, its precision can be affected by factors ...
John Eimen, a former child star known for his guest spot in "Leave it to Beaver," died Friday, Nov. 21, a representative confirmed. He was 76. Eimen died at his home in Mukilteo, Washington, from ...
Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...